Studies

  1. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus

  2. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts

  3. Proton pump inhibitors use and risk of inflammatory bowel diseases: a meta-analysis of observational studies

  4. Use of contraceptives and risk of inflammatory bowel disease: a nested case-control study

  5. Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study

  6. Systematic review with meta-analysis: environmental and dietary differences of IBD in Eastern and Western populations

  7. Proton Pump Inhibitor Use Before and After a Diagnosis of Inflammatory Bowel Disease

  8. Prevalence and Risk Factors Associated With Inflammatory Bowel Disease in Patients Using Proton-Pump Inhibitors: A Population-Based Study

  9. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study

  10. The inflammatory bowel diseases and ambient air pollution: a novel association